Palvella Therapeutics PVLA
NASDAQ PVLA
$132.47 -0.26 (-0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Depreciation & Amortization (CF) (2014 - 2024)

Updated

Palvella Therapeutics (PVLA) posted Depreciation & Amortization (CF) of -$30,000 for Q1 2024, compared with $605,000 a year earlier.

Analysis

Palvella Therapeutics (PVLA) Depreciation & Amortization (CF) (2014 - 2024) Analysis & Trends

For FY2023, Palvella Therapeutics' Depreciation & Amortization (CF) came in at $1.9 million, down 31.3% from FY2022.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 26.0% (FY2018 to FY2023).
  • In prior years, Palvella Therapeutics' Depreciation & Amortization (CF) was $2.77 million in FY2022 (+12.6%), $2.46 million in FY2021 (+6.4%), $2.31 million in FY2020 (+265.7%) and $632,000 in FY2019 (+5.3%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of -$198,000 in Q4 2023 to a high of $845,000 in Q1 2022 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in two of the last six quarters, with growth averaging 2.2%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2020, with growth of 374.2%; the weakest was Q2 2019, with a decline of 70.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was -$198,000 (Q4 2023), $739,000 (Q3 2023) and $758,000 (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Palvella Therapeutics 1.91 Bn 1.66 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -30,000.00
Dec 31, 2023 -198,000.00
Sep 30, 2023 739,000.00
Jun 30, 2023 758,000.00
Mar 31, 2023 605,000.00
Dec 31, 2022 575,000.00
Sep 30, 2022 767,000.00
Jun 30, 2022 583,000.00
Mar 31, 2022 845,000.00
Dec 31, 2021 609,000.00
Sep 30, 2021 608,000.00
Jun 30, 2021 617,000.00
Mar 31, 2021 625,000.00
Dec 31, 2020 688,000.00
Sep 30, 2020 754,000.00
Jun 30, 2020 530,000.00
Mar 31, 2020 339,000.00
Dec 31, 2019 265,000.00
Sep 30, 2019 159,000.00
Jun 30, 2019 42,000.00
API Access

Palvella Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PVLA&period=max&api_key=YOUR_API_KEY